LiVDerm Podcasts

This is the second episode of a two-part miniseries, “IL-31 Inhibition for Treatment of Prurigo Nodularis” series, supported by an educational grant from Galderma. Hosted by expert dermatologist and neuroscientist Dr. Sarina Elmariah, MD, PhD, MPH, this episode, “IL-31 Mechanism and Clinical Implications for PN”, featuring Dr. Shawn Kwatra, discusses the following topics:

• Mechanism of action for IL-31 inhibitor nemolizumab
• Clinical safety and efficacy data for nemolizumab for treatment of PN
• Strategies for prescribing IL-31 inhibitors in clinical practice
• Pearls for patient selection and addressing treatment challenges

This is the sixth episode of our ongoing “Program on JAK Inhibitors for Atopic Dermatitis” series, hosted by expert dermatologist Dr. Christopher Bunick, MD, PhD. This episode, “Achieving More: How and When to Switch Systemic Therapies in Atopic Dermatitis?”, featuring Beth Sweney, PA-C discusses the following topics:

• Challenges in achieving treatment targets in AD
• Therapeutic inertia and clinical implications of inadequate response
• Comparative clinical data evaluating upadacitinib and dupilumab for treatment of AD
• Transitioning to systemic therapies from topical agents, immunosuppressives, and biologic therapies

This is the second episode of a two-part educational series to raise awareness of epidermolysis bullosa (EB) and the latest FDA-approved treatment options for this disease. Our host, Dr. Michael Lavery, a Pediatric Dermatologist and Clinical Assistant Professor at the University of Florida in Gainesville, FL, is joined by Dr. Joyce Teng, MD, PhD, Professor of Dermatology and Pediatrics at Stanford University School of Medicine in Stanford, CA, as they discuss the following topics:

• Setting the stage for treating a patient with EB
• Assessing EB severity and subtype to inform treatment
• Expert review of the current FDA-approved treatments and
• Strategies to close care gaps for EB patients

This is the first episode of a two-part educational series to raise awareness of epidermolysis bullosa (EB) and the latest FDA-approved treatment options for this disease. Our host, Dr. Joyce Teng, MD, PhD, Professor of Dermatology and Pediatrics at Stanford University School of Medicine in Stanford, CA, is joined by Dr. Michael Lavery, a Pediatric Dermatologist and Clinical Assistant Professor at the University of Florida in Gainesville, FL, as they discuss the following topics:

• Epidemiology and prevalence of EB
• Burden of disease and impact on patients’ quality of life
• Gaps and challenges for patients with EB
• Assessing the current knowledge of clinicians and gaps in care recommendations

This podcast episode, sponsored by Leo Pharma, features LiVDerm faculty and esteemed dermatologists Dr. Christopher Bunick, MD, PhD, and Dr. Jonathan Silverberg, MD, PhD, MPH. As experts in all things concerning eczema, our faculty discuss the differentiating features and disease burden in patients suffering from chronic hand eczema (CHE) and review the current guidance for treatment, including these specific topics:

• Differentiating CHE from atopic dermatitis of the hands, including triggers, pathophysiology, and clinical presentation
• Expert guidance for accurate diagnosis and work-up of CHE patients
• Challenges and limitations of current therapeutic offerings
• The potential of a topical novel pan-JAK inhibitor for targeted treatment of CHE

Click here to access the slide deck referenced in this podcast episode.

This is the first episode of a two-part miniseries, “IL-31 Inhibition for Treatment of Prurigo Nodularis” series, supported by an educational grant from Galderma and hosted by prurigo nodularis (PN) expert Dr. Shawn Kwatra, MD. This episode, “Examining the Gaps and Challenges in Diagnosing and Treating Prurigo Nodularis”, featuring expert dermatologist and neuroscientist Dr. Sarina Elmariah, MD, PhD, MPH, discusses the following topics:

• The lack of awareness and timely, correct diagnosis of PN patients
• Strategies for assessing patients with PN and alleviating disease symptoms and burden
• Examining the current expert guidance and available therapies for treating PN
• Looking to the future of PN diagnosis and targeted treatment

This is the second episode of a two-part activity on “Skirting Steroids in Atopic Dermatitis”, supported by an educational grant from Arcutis Biotherapeutics, Inc., and hosted by expert dermatologist Dr. Christopher Bunick, MD, PhD. This episode, “New Therapies and Expert Strategies for Long-term Control”, featuring expert dermatologist Dr. Jonathan Silverberg, MD, PhD, MPH, discusses the following topics:

• The pros and cons of steroid use in treating AD
• Targeted non-steroidal topical therapies approved by the FDA
• Relevant clinical efficacy and safety data for new and emerging non-steroidal topicals
• Recommendations for long-term symptom control in AD patients

Click here to access the slide deck referenced in this podcast episode.

This is the fifth episode of our new “Program on JAK Inhibitors for Atopic Dermatitis” series, hosted by expert dermatologist Dr. Christopher Bunick, MD, PhD. This episode, “Choosing the Right Path: JAK Inhibitors or Biologics for Atopic Dermatitis?”, featuring expert dermatologist Dr. Naiem Issa, MD, PhD, discusses the following topics:

• Mechanistic differences between JAKi and biologics for treatment of AD
• Clinical data supporting the safety of JAKi in head-to-head trials compared to biologics
• Pearls for prescribing JAKi to AD patients
• Strategies for choosing JAKi vs biologics based on safety and patient factors

This is the first episode of a two-part activity on “Skirting Steroids in Atopic Dermatitis”, supported by an educational grant from Arcutis Biotherapeutics, Inc., and hosted by expert dermatologist Dr. Christopher Bunick, MD, PhD. This episode, “Dangers and Side Effects of Steroid Exposure in Treatment of AD”, featuring expert dermatologist Dr. Peter Lio, MD, discusses the following topics:

• Side effects of topical and oral corticosteroid exposure
• Pearls and gaps in current guidelines for treatment of AD
• Identifying topical steroid withdrawal symptoms
• Safety and stewardship strategies for topical steroids
• Future of non-steroidal advanced topical therapies for AD

Click here to access the slide deck referenced in this podcast episode.

This is the fourth episode of our new “Program on JAK Inhibitors for Atopic Dermatitis” series, hosted by expert dermatologist Dr. Christopher Bunick, MD, PhD. This episode, “Setting the Stage: Effective Onboarding of your AD Patients onto JAK Inhibitor Therapy”, featuring expert dermatologist Dr. Ruth Ann Vleugels, MD, MPH discusses the following topics:

• Identifying ideal candidates for oral JAK inhibitor therapy
• Steps to initiate therapy and onboard new patients
• How to manage side effects and maintain adherence to treatment
• Case examples and real-world data

This is the third episode of our new “Program on JAK Inhibitors for Atopic Dermatitis” series, hosted by expert dermatologist Dr. Christopher Bunick, MD, PhD. This episode, “The Quest for Itch-Free, Clear Skin in Atopic Dermatitis: New Practice-Informing Evidence”, featuring expert dermatologist Dr. Jonathan Silverberg, MD, PhD, MPH, discusses the following topics:

• Overall impact of atopic dermatitis on patients’ quality of life
• Overview of the role of various existing treatments for AD and expert guidelines
• Discussion of LEVEL UP clinical trial data comparing upadacitinib and dupilumab
• Defining treatment success and best practices for treatment selection

This special podcast episode, developed in collaboration with UCB, features LiVDerm faculty and esteemed dermatologists Dr. Jennifer Hsiao, MD, and Dr. Hadar Lev-Tov, MD. As experts in all things hidradenitis suppurativa (HS), our faculty discuss the need for early and accurate diagnosis and assessment of patients with HS in order to prescribe treatment at the best time to achieve disease control, including the following topics:

1. Key challenges in treating patients with moderate-to-severe HS
2. The role of targeted, systemic therapies in HS management
3. Defining “moderate” disease and strategies for severity assessment
4. Defining window of opportunity and strategies for advanced treatment of HS
5. Defining and assessing treatment response and success with targeted therapies

This is the second episode of our new “Program on JAK Inhibitors for Atopic Dermatitis” series, hosted by expert dermatologist Dr. Christopher Bunick, MD, PhD. This episode, “JAK Inhibitors in Action: Effectiveness in Atopic Dermatitis”, featuring expert dermatologist Dr. James Song, MD, discusses the following topics:

1. Short- and long-term efficacy and safety data for JAK inhibitor therapies
2. New topline data from the LEVEL UP trial studying upadacitinib in comparison to dupilumab for the treatment of patients aged 12 years and older with moderate-to-severe AD
3. Head-to-head studies and real-world evidence evaluating JAK inhibitor therapies
4. Emerging clinical developments and what’s coming next in JAK inhibitor research

This is the fourth and final episode of the, “Psoriasis in Skin of Color Unplugged” series, hosted by expert dermatologist Dr. Mona Shahriari who will be discussing the gaps in care for psoriasis patients with skin of color. This episode, “Patient and Disease Advocacy”, featuring Jason Harris, the VP of Government Relations and Advocacy at the National Psoriasis Foundation (NPF), discusses the following topics:

• Patient perspective on challenges to receiving treatment for their psoriasis
• NPF efforts to address patient challenges and access to care issues
• Relevant survey and research data on disparities specific to SoC and socioeconomic status
• Consideration of impact on quality of life in determining access to systemic treatments

If you have any questions about NPF efforts to advocate for patients with psoriasis, please reach out to Jason Harris via email at jharris@psoriasis.org or visit the NPF website.

This is the third episode of the, “Psoriasis in Skin of Color Unplugged” series, hosted by expert dermatologist Dr. Mona Shahriari who will be discussing the gaps in care for psoriasis patients with skin of color. This episode, “Advancing Diversity and Inclusion in Clinical Trials”, featuring expert dermatologists Dr. Andrew Alexis and Dr. Jennifer Soung, discusses the following topics:

• Underrepresentation of diverse patients, investigators, and trial sites in clinical studies
• FDA efforts to improve clinical trial diversity and education
• The impact that current clinical trials focusing on SOC are having on patient care
• High-level findings from the VISIBLE trial studying psoriasis patients of color

This is the second episode of the, “Psoriasis in Skin of Color Unplugged” series, hosted by expert dermatologist Dr. Mona Shahriari who will be discussing the gaps in care for psoriasis patients with skin of color. This episode, “Gaps in Diagnosis and Dermatologist Training”, featuring expert dermatologist Dr. George Han, discusses the following topics:

• Difference in clinical presentation of psoriasis in SoC
• Barriers to early and accurate diagnosis and dangers of delayed diagnosis
• Gaps in medical student and residency education
• Lack of SoC images in medical textbooks, public images, and advertising

This is the first episodes of a new series, “Psoriasis in Skin of Color Unplugged”, hosted by expert dermatologist Dr. Mona Shahriari who will be discussing the gaps in care for psoriasis patients with skin of color. This episode, “Disparities and Access to Care”, featuring expert dermatologist Dr. Candrice Heath, discusses the following topics:

• Increased severity of psoriatic disease in patients of color
• Challenges associated with access to specialist care
• Stigma surrounding psoriasis in patients of color
• Gaps in culturally competent care

This is the first episodes of a new series hosted by expert dermatologist Dr.
Christopher Bunick who will be discussing the evolving role of JAK inhibitor
therapies in the management of atopic dermatitis (AD). This episode, “The
Spectrum of Atopic Dermatitis and the Emerging Role of JAK Inhibitors”,
featuring expert dermatologist Dr. John Koo, discusses the following topics:

• Understanding atopic dermatitis as a spectrum disorder, phenotypes and
  endotypes, and heterogeneity of atopic disease
• Summarizing JAK inhibitor therapies, including clinical safety and efficacy
  and mechanism of action
• Comparison of JAKi to biologics and traditional systemic agents, and the
  evolving role of JAKi in treatment of AD

In support of Eczema Awareness Month, LiVDerm sat down with one of the nation’s top experts on atopic dermatitis, Christopher G. Bunick, MD, PhD, to discuss this widespread skin condition that affects millions worldwide.

Associate professor of dermatology at Yale University School of Medicine, Dr. Bunick covers emerging targeted therapies and also looks at the concerns over their safety and efficacy. He also addresses some of the gaps that persist in treatment despite these new therapies.

In support of Eczema Awareness Month, LiVDerm sat down with one of the nation’s top experts on atopic dermatitis, Peter A. Lio, MD, to discuss this widespread skin condition that affects millions worldwide.

Dr. Lio, a clinical assistant professor of dermatology and pediatrics at Northwestern University Feinberg School of Medicine, focuses on caring for pediatric patients with eczema in his interview. He provides unique insight into how best to combine integrative and pharmacologic treatments.

Brett King, MD, PhD, who spoke on the live satellite symposium “Gamechangers in Alopecia Areata” at the SBS 2023 meeting, speaks out about the rising use of JAK inhibitors to treat patients with alopecia areata.

Questions:

1. JAK inhibitors are taking the dermatology field by storm, with several approvals for multiple dermatologic conditions over the past couple of years. What is it that makes JAK inhibitors a gamechanger for treatment of alopecia areata?
2. In 2022, the first ever targeted treatment for alopecia areata, baricitinib, was approved by the FDA for adult patients. What additional treatments or FDA approvals can we expect to see in 2023?
3. Thank you for your time today, Dr King. This was fantastic. Is there anything else you’d like to add?

Brittany Craiglow, MD, who spoke on the live satellite symposium “Gamechangers in Alopecia Areata” at the SBS 2023 meeting, shares her personal approach to treating pediatric patients with alopecia areata.

Questions:

1. What is your personal approach to developing a treatment plan with your patients and/or their caregivers? Do find yourself utilizing shared decision-making or other nuances to communicating with patients and caregivers?
2. You mainly treat pediatric and adolescent patients for hair loss in your clinical practice. Are there any specific nuances you’d like to share in regard to treating pediatric versus adult patients suffering from hair loss?
3. Thank you for your time today, Dr Craiglow. This was wonderful. Is there anything else you’d like to add?

Elaine Siegfried, MD, who spoke on the live satellite symposium “Infants and Atopic Dermatitis” at the MOPD 2023 meeting, shares her expert advice for formulating a treatment plan and incorporating newer treatment options when managing pediatric patients with atopic dermatitis.

Questions:

1. With recently expanded age indications for therapeutic agents to treat pediatric AD, what steps should clinicians consider when formulating a treatment plan for their younger patients?
2. The treatment landscape for atopic dermatitis in pediatric patients has shown much growth over the past couple of years. How do you foresee the treatment landscape continuing to change in 2023?
3. This was excellent, Dr Siegfried, thank you for your time. Is there anything else you’d like to add?

Lawrence Schachner, MD, chair of the MOPD meeting and expert faculty who spoke on the live satellite symposium “Infants and Atopic Dermatitis”, shares clinical pearls for early and accurate diagnosis of atopic dermatitis in younger pediatric patients, as well as challenges often faced when assessing pediatric patients with skin of color.

Questions:

1. Can you share your top pearls for early and accurate recognition of atopic dermatitis in infants?
2. What gaps do you feel persist in the diagnosis and assessment of atopic dermatitis in infants, particularly those with skin of color?
3. Thank you for your time today, Dr Schachner. This was fantastic. Is there anything else you’d like to add?

Mercedes Gonzalez, MD, who spoke on the live satellite symposium “Infants and Atopic Dermatitis” at the MOPD 2023 meeting, shares clinical pearls for improving communication with patients and caregivers of patients with atopic dermatitis.

Questions:

1. Caregivers often voice concerns regarding safety and side effects of newer systemic treatments for atopic dermatitis. What can clinicians do to better educate and reassure their patients and caregivers? How does shared decision-making factor into this?
2. What gaps do you feel persist regarding the communication between clinicians and their patients/caregivers? What can clinicians do to address these gaps?
3. Thank you for your time today, Dr Gonzalez. This was very informative. Is there anything else you’d like to add?

Our theme, Deeper Than the Surface, was born based on what sets South Beach Symposium (SBS) apart from any of the other hundreds of dermatology meetings out there, and that’s how SBS truly delivers equal parts Clinical and Aesthetic Dermatology Education. Featuring Dr. Goldberg, a MOHS surgeon listed in headlines for new acne therapies and the longtime Chair of our Cutaneous Oncology Track at SBS, along with Dr. Gold and his extensive clinical trial experience, which he heads in his Nashville practice, this podcast shares an in-depth discussion of how much of their actual clinic time is spent on medical dermatology and their involvement in breaking clinical trials for medical dermatology therapies. Listen now to hear a truly insightful review of SBS as an educational meeting and how it has changed with leaders like Drs. Gold and Goldberg at the helm.

Podcast regarding the efficacy and safety of IL-13 inhibitors for the treatment of AD.

• What factors should clinicians consider when selecting a biologic or systemic therapy to manage atopic dermatitis?
• Effectively and promptly diagnosing atopic dermatitis can be a bit tricky at times. What is your personal approach for effective diagnosis?
• Which patients would benefit most from an integrative approach to managing atopic dermatitis?
• How can clinicians execute effective shared decision-making strategies in the management of chronic skin conditions?

Christopher Bunick, MD, PhD, LiVDerm faculty and member of the SBS Planning Committee, shares key takeaways from his session at the SBS 2022 event regarding IL-13 inhibitors for treatment of AD and the underlying disease pathogenesis.

• With the several ongoing advances in the availability of more treatment options for managing atopic dermatitis, how can the practicing clinician best select the most appropriate treatment option that will address the underlying causes of disease progression?
• As with most treatment options for chronic conditions, side effects often occur. What considerations should clinicians remember when discussing treatment-related adverse events with their patients?
• Atopic dermatitis is stated to impact several areas of a patient’s life, including the quality. How can clinicians best address this issue from a patient-centered perspective?
• What key takeaways should clinicians consider when constructing a management plan for chronic illnesses such as moderate to severe atopic dermatitis?

We are honored to speak to Klint Peebles, MD, the chair of LiVDerm’s Sexual and Gender Diverse Dermatology Summit: Fundamentals and Practical Pearls and past chair of the American Academy of Dermatology’s Expert Resource Group on Sexual and Gender Diverse Health.

Dr. Peebles, a board-certified dermatologist with Kaiser Permanente, Mid-Atlantic Permanente Medical Group, has extensive clinical, leadership, and research expertise in sexual and gender diverse health and gender-affirming dermatology. Dr. Peebles currently serves on the LGBTQ Health Specialty Section Council of the American Medical Association. Dr. Peebles mentions some of the key reasons why you don’t want to miss the Sexual and Gender Diverse Dermatology Summit: Fundamentals and Practical Pearls in California October 15-16, 2022! – Register here: www.livderm.org/live-events/sexual-and-gender-minority/

Topics Dr. Peebles covers include:

• We are so excited to welcome you as the conference chair of our upcoming Sexual and Gender Diverse Dermatology Summit in Southern California this October 15-16. What unique experiences do you bring to this conference and why is this patient population so important in the dermatologic field?
• Although there are certain aspects of aesthetic medicine in caring for sexual and gender diverse patients, would you consider this area of the discipline falling under the category of medical dermatology, or is it not necessary to differentiate? Do you expect practitioners of both cosmetic and general dermatology to benefit from the Summit?
• Your wealth of experience, leadership, and advocacy in the field of better medical care for the sexual and gender diverse patient population has no doubt improved outcomes and quality of life. Can you tell us about some of your career highlights and moments when you could see actionable change as a result of your efforts?
• The Sexual and Gender Diverse Summit, taking place within SBS: West Coast Derm this October 2022 at the Terranea Resort is a milestone event for LiVDerm. Do you think the location of the event just outside of Los Angeles, California, is indicative of the sexual and gender diverse population and the providers who see them? Do you see events like this someday soon being held in smaller, more rural regions of the U.S. where fewer resources or social determinants may mean that sexual and gender diverse patients face even larger roadblocks to care?
• Is the field of dermatology seeing improvements in nondiscrimination, acceptance, welcoming environments, affirming language, and dedicated initiatives to improve safety, and can you explain some of those efforts within the context of guidelines or policy?

www.livderm.org

Internationally renowned dermatologist, Doris Day, MD, who recently was named one of the top 5 dermatologists in America for 2022, gives us the latest updates in aesthetic and medical dermatology. She also mentions some of the key reasons why you don’t want to miss the upcoming South Beach Symposium in Miami, FL – and SBS West in California!

Dr. Day specializes in laser, cosmetic and surgical dermatology. She lectures nationally and internationally on the latest aesthetic techniques to both her peers and to the public. As a highly respected and sought-after personality in the area of cosmetic dermatology, Dr. Day has been featured in the media, and serves on medical advisory boards and training panels where she teaches other physicians the art of soft tissue fillers, laser treatments and facial rejuvenation techniques.

Topics she covers include:

1. You are sought after not only by patients for your clinical expertise, but also by the media to weigh in on trending topics in cosmetic dermatology. How did you cultivate such a respected position in this industry, and what responsibilities come with having such a wide reach?
2. You’re also an author. Did you enjoy the writing process, and do you think you’ll publish more books in the future?
3. This August, LiVDerm is honored to welcome you back to Miami Beach for the 20th Anniversary of South Beach Symposium. Tell us a bit about the history of the event and what aspects you look forward to each year.
4. You’ll deliver sessions at this year’s South Beach Symposium addressing important topics in both aesthetic and medical dermatology. Do some topics, such as female sexual rejuvenation, actually encompass both disciplines?
5. South Beach Symposium is extending our reach this October by hosting a conference in California. As an East Coaster, what differences do you think attendees at SBS: West Coast Derm can expect from education focused on the aesthetic needs of West Coast clientele?

Please listen as nationally-renowned innovator, artist, and scientist, Jason J. Emer, MD, shares the secrets to redefining perfection.

Dr. Emer is well-known throughout the nation as the master of his field. He is redefining the world of liposuction and body shaping, one impeccably-sculpted client at a time. Dr. Emer pushes the boundaries of what’s possible – earning him a well-deserved reputation as the man behind some of Beverly Hills’ most notorious bodies. This is a must-listen episode!

Prefer to read instead? You can find the full transcript for this podcast here.

Don’t forget to rate, subscribe or follow DermDocs, and leave us a five star review!

Topics he covers include:

1. Because June is Men’s Health Month, LiVDerm is featuring some topics that pertain specifically to men. You specialize in both surgical and nonsurgical methods to reshape the nose. How do these services relate specifically to your male patients – and have you seen an increase in demand from male patients in recent years?
2. South Beach Symposium is expanding our reach to the West Coast for a first-ever conference this October 14-16. As one of the most prominent dermatologists in California, what can the audience expect from SBS: WEST COAST DERM, a meeting geared towards the needs of a West Coast clientele?
3. Can you give our listeners a glimpse into plasma pen treatments for nonsurgical skin rejuvenation and explain why patients have been so enthusiastic about these treatments and the results?
4. How can chemical peel treatments enhance the results of injectables like fillers and botox?
5. Why is the heart-shaped face such a visually appealing aesthetic, and what injection techniques can providers use to achieve it?
6. And finally, we are so excited to welcome you to Miami Beach this August for your much-anticipated sessions at South Beach Symposium! Among all the topics you’ll be covering, you’ll also take part in the Star Panel: Expert-Led Discussion of Practice Management for Cosmetic Dermatologists. Why is it so important for dermatologists to come together in forums like this, and what can attendees learn from these interactions between the experts beyond just a traditional lecture?

Listen as world-renowned dermatologist, Michael H. Gold, MD, FAAD, gives us great insight on energy-based devices, and how they treat a myriad of skin conditions. He also uncovers the latest advances in scar treatment. It’s an episode you won’t want to miss!

Dr. Gold is a board-certified dermatologist and dermatologic surgeon. He is world-renowned for providing patients with leading-edge technological advances in dermatology. He was also recently named one of the top three dermatologists in Nashville.

Topics he covers include:

1. 1. You are regularly named to top doctors lists, and were recently named one of the three best dermatologists in Nashville. What’s your philosophy for maintaining a robust clientele and high patient satisfaction? Can attendees at South Beach Symposium expect to learn ways to improve their business practices, in addition to cutting-edge clinical techniques?
   2. You are world-renowned for your expertise in energy-based devices to treat a myriad of skin conditions. Tell us about the success you’ve seen specifically using EBDs in patients with skin of color.
   3. Tell us a little about the sessions you’ll be presenting at this year’s South Beach Symposium. Are there similarities in treating both acne and rosacea with energy-based devices? And what will attendees learn in your session on microneedling?
   4. Are lasers for hair loss the future of alopecia treatment? Briefly, how do they work, what is the course of treatment, and how can providers predict or determine which patients will see improvements? Is this treatment specifically for alopecia-related hair loss, or does it translate to male-pattern and age-related hair loss and thinning, as well?
   5. You are on the cutting-edge of new approaches in scar treatment. Is this an area where medical and cosmetic dermatology collide? What is the latest technology in this area? Are there challenges to achieving optimal results that providers should be aware of?

Dr. Z. Paul Lorenc, M.D., shares insights about cellulite protocols, facial structure techniques, and why you should attend his live cadaver workshop this fall. Other topics he covers in this part 2 special include:

1. When deciding how to manage cellulite, which patient characteristics do you consider most strongly when selecting a course of treatment?
2. Why is an understanding of facial anatomy so important, particularly in the lower face and jaw, for providers when selecting injection patterns?
3. You may know that South Beach Symposium is expanding to the West Coast this Fall. Because you practice in New York but teach and lecture nationwide, do you notice different aesthetics on the East vs. West Coasts?
4. What might a West Coast provider audience be more interested in learning based on their patients’ needs?
5. LiVDerm education isn’t just for dermatologists. How would you say our extender audience of physician assistants, nurse practitioners, and other providers can benefit from SBS, and particularly from your Cadaver Workshop?

Listen as internationally known dermatologist, David Goldberg, M.D., J.D., gives us insight into how to prevent skin cancer – as well as shares some of the latest and greatest advancements in dermatology in part 2 of his podcast series. Dr. Goldberg is known for his work using cutaneous lasers and other noninvasive facial and body rejuvenation techniques. He is active in clinical practice as the director of Skin Laser & Surgery Specialists of New York and New Jersey, and as a clinical professor of dermatology at Mount Sinai School of Medicine and Rutger’s New Jersey Medical School.

Don’t forget to rate, subscribe or follow DermDocs, and leave us a five star review!

Topics he covers include:

1. As former Co-Vice President of the Skin Cancer Foundation, you know that even though improvements in detection, therapeutics, and surgery for skin cancer are increasing long-term survival, prevention is still the key. How will your session in the Cutaneous Oncology Symposium at the August’s South Beach Symposium spotlight skin cancer prevention?

2. What are some strategies you use to encourage sunscreen use in your patients?

3. You earned your Medical Degree from Yale, and completed your dermatology residency and dermatologic surgery fellowship at New York University Medical Center. Do you have advice for medical students or residents interested in pursuing a career in dermatology, knowing it is one of the most competitive subspecialties?

4. Do you think attending a LiVDerm event could give students a competitive edge? Mentorship is essential – could networking at a LiVDerm event connect future dermatologists with industry mentors?

5. With expertise in both cosmetic and medical dermatology, what do you think are the biggest advancements in each field this year? How can providers  incorporate these new technologies or strategies into their practice and how will they benefit their patients?

Listen as internationally known dermatologist, David Goldberg, M.D., J.D., gives us some of the latest tips and tricks about skin rejuvenation in this part I podcast special. Dr. Goldberg is known for his work using cutaneous lasers and other noninvasive facial and body rejuvenation techniques. He is active in clinical practice as the director of Skin Laser & Surgery Specialists of New York and New Jersey, and as a clinical professor of dermatology at Mount Sinai School of Medicine and Rutger’s New Jersey Medical School.

Don’t forget to rate, subscribe or follow DermDocs, and leave us a five star review!

Topics he covers include:

1. You have published extensively on laser dermatology and will present a session at the upcoming South Beach Symposium on energy-based devices for body contouring. How do energy-based devices differ from lasers, and can you give some examples of a patient that would benefit from each type of treatment?

2. As a member of the South Beach Symposium Planning Committee, what informs the topics you put on the agenda each year? Do you rely most heavily on recent research developments, therapeutics showing promise in trials, or your personal experience with what see in your practice?

3. One session South Beach Symposium attendees look forward to each year is the Live Patient Injection Demonstration, which you’ll be taking part in. What are some principles of using injectables for body contouring and rejuvenation that our audience can expect to learn?

Listen as Patrick Bitter Jr., M.D., F.A.A.D. shares insights about why light is so important when it comes to keeping your skin healthy. You don’t want to miss these tips from Dr. Bitter – who was just featured in the cover story of Top Doctor Magazine‘s March 2022 issue for his discovery of pulsed light and its usefulness, effectiveness, and versatility in treating a multitude of skin problems, as well as delaying skin aging, and maintaining healthy skin, as an adjunct to a cosmetic surgical practice in the treatment of post-surgical scars – in other words, finding the “fountain of youth”.

Don’t forget to rate, subscribe or follow DermDocs, and give us a five-star review!

Prefer to read instead? You can find the full transcript for this podcast here.

Topics he covers include:

1. You’ll present a session at the 2022 South Beach Symposium discussing energy-based devices for facial rejuvenation. Can you give listeners a glimpse of what will be covered?
2. What technology would suggest for a patient with acne scarring or uneven skin texture who hasn’t seen results from first-line treatments?
3. You developed the FotoFacial Procedure; who is a candidate for this service and what are the benefits?
4. The COVID-19 pandemic has revealed some unexpected challenges for providers in many medical subspecialties. Have you observed any new patient complaints, surge requests for certain procedures, or other phenomenons you attribute to the pandemic?
5. Your practice is in California – SBS is launching a new event at the Terranea Resort in Southern California this Fall! Can you explain if patients on the West Coast have different aesthetic ideals than East Coast patients?
6. What nuances do you think attendees at SBS WEST will experience in an agenda tailored to a West Coast audience?

Dr. Z. Paul Lorenc, M.D., shares insights about why science is your guide and anatomy is your savior. He will be leading the hands-on cadaver workshop at the South Beach Symposium this August, and you don’t want to miss it! Other topics he covers include:

1. Why is a mastery of facial anatomy principles non-negotiable for cosmetic dermatologists who offer soft tissue fillers?
2. Can you explain the basic differences between facial fillers and neurotoxins – and how to use both injectables in the same patient successfully?
3. You’ll lead the intensive Hands-On Cadaver Workshop at the 2022 South Beach Symposium. Please Explain what attendees will experience during this comprehensive training – and how the skills gained will be actionable in their practices.
4. You’ve pioneered some industry-defining cosmetic techniques and procedures. Can you explain how these minimally invasive services contribute to patient satisfaction, and if the availability of noninvasive cosmetic technologies has resulted in fewer requests for more invasive surgical procedures?
5. “Science is your guide. Anatomy is your savior.” Can you explain how this quote on your website exemplifies the cosmetic dermatology specialty, and how you’ll infuse this concept into your instruction of the Hands-On Cadaver Workshop this year at SBS?

Dr. Dr. Doris Day, M.D., F.A.A.D., M.A. shares insights about the latest trends and new developments in dermatology today, including:

1. As a member of the South Beach Symposium Planning Committee, you help design and curate the agenda. How do you decide which topics should be covered; do you rely on issues or concerns you see in your practice, or emerging therapeutics/devices/technologies?
2. In the past 20 years of South Beach Symposium, what are some sessions or topics we covered that proved to be on the cutting-edge of industry developments?
3. In your opinion, is it more beneficial for dermatologists to have either a cosmetic, medical, or surgical practice and build a reputation as an expert in one area, or is it more advantageous to offer many dermatologic services? (tie this into SBS having sessions on all areas)
4. Dermatology is known as one of the most competitive medical specialties. What would your advice be to medical students or residents pursuing a dermatology fellowship and career? (maybe this could lead in to more students/residents attending SBS)
5. The recent approval of JAK inhibitors to treat atopic dermatitis is an exciting development in medical dermatology. Are there any devices or technologies emerging on the aesthetic side you are excited about? (tie this into a session on lasers or fillers?)
6. How do you think LiVDerm’s partnership will elevate the education and resources available to valued South Beach Symposium attendees?
7. Do you see any gaps in the current dermatologic training? Do you see efforts by LiVDerm and South Beach Symposium to address those gaps (if any) and is that a draw for clinicians to seek conferences like ours? (Skin of Color comes to mind, or women in dermatology? Any underutilized therapies or gut-skin connection strategies?)

Dr. Dr. Glynis Ablon, M.D., F.A.A.D. shares some insightful knowledge about the latest developments in dermatology and how to keep your patients feeling confident and vivacious.

1. As a member of the South Beach Symposium Planning Committee, you help design and curate the agenda. How do you decide which topics should be covered; do you rely on issues or concerns you see in your practice, or emerging therapeutics/devices/technologies?
2. In your opinion, is it more beneficial for dermatologists to have either a cosmetic, medical, or surgical practice and build a reputation as an expert in one area, or is it more advantageous to offer many dermatologic services? (tie this into SBS having sessions on all areas)
3. Dermatology is known as one of the most competitive medical specialties. What would your advice be to medical students or residents pursuing a dermatology fellowship and career? (maybe this could lead in to more students/residents attending SBS)
4. The recent approval of JAK inhibitors to treat atopic dermatitis is an exciting development in medical dermatology. Are there any devices or technologies emerging on the aesthetic side you are excited about? (tie this into a session on lasers or fillers?)
5. Do you see any gaps in the current dermatologic training? Do you see efforts by LiVDerm and South Beach Symposium to address those gaps (if any) and is that a draw for clinicians to seek conferences like ours? (Skin of Color comes to mind, or women in dermatology? Any underutilized therapies or gut-skin connection strategies?)

Dr. Bruce Katz, MD, shares some emerging treatments in dermatology including:

1. The global facial injectables market size is expected to reach USD 9.07 billion by 2028 (the market size stood at USD 4.46 billion in 2020): What does this mean for aesthetic medicine providers, are there more ways to capitalize on this growth other than simply offering injectables?
2. Which new or emerging laser technology or treatment should providers have their eyes on, or consider offering in their practice if they don’t already?
3. For someone interested in facial rejuvenation but hesitant to commit to surgery, which noninvasive or minimally invasive procedure delivers the best results with little downtime?
4. You practice both clinical and aesthetic dermatology – which field has the most growth potential for new practitioners? If a dermatology student or resident were deciding between dermatologic subspecialties, what would your advice to them be?
5. Your partnership with LiVDerm as faculty at many of our prestigious events draws quite a following. What do you think LiVDerm offers our attendees that other conferences do not? What are providers who’ve never been to a LiVDerm event missing?
6. February is Black History Month – LiVDerm has dedicated resources and programming to address dermatologic conditions that disproportionately affect or burden people with skin of color (SOC) such as African Americans. What is your experience in this area, and how can the dermatology community lessen these disparities?

Dr. Peter Lio, MD, shares some highlights about the treatment of atopic dermatitis in pediatric patients including:

1. Can you tell us about the number of emerging therapies for the treatment of atopic dermatitis in pediatric patients and how this has changed the treatment landscape?
2. What is your personal approach to treating atopic dermatitis in pediatric patients?
3. What made you decide to found the Chicago Integrative Eczema Center to prevent atopic dermatitis in children?
4. Can you share some advice for dermatologists on communicating with parents and caretakers of pediatric atopic dermatitis patients regarding treatment options?
5. Are there any other tips that you recommend to your patients when explaining to them how to manage their skin diseases?
6. If you could be known for one thing, what would it be?!